CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop a pain-free treatment for atrial fibrillation by using optogenetics to control heart rhythms. An implantable device will deliver light pulses to restore normal rhythm without the need for sedation or high-voltage shocks.
Atrial fibrillation (AF) is the most common type of heart rhythm disturbance, progressive in nature and associated with high morbidity and mortality.
Thus, an effective and broadly applicable treatment to quickly restore normal rhythm at any time and place is highly desired.
However, such therapy is lacking.
In contrast to drugs and ablation, electrical cardioversion of AF is effective in broad populations of AF patients, but can only performed within hospitals because of the required patient se…
Leiden University Medical Center
ACADEMISCH ZIEKENHUIS LEIDEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Netherlands, Amsterdam
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
